China has granted a six-year protection period for clinical trial data on innovative drugs, the National Medical Products Administration said on Friday. The six-year protection applies to innovative drugs and originator drugs, calculated from the date of drug registration. Improved new drugs receive four years of data protection, and first generic drugs receive three years, according to a guideline issued by the a

Chinese companies and researchers filed a record 22,031 patent applications with the European Patent Office (EPO) in 2025, with China rising to third place for the first time, the EPO Technology Dashboard 2025 showed on Tuesday. The figure marked a year-on-year increase of 9.7 percent and accounted for 10.9 percent of all applications filed at the EPO, making China the fastest-growing country among the top 10 fili

Chinese courts concluded more than 2.5 million first-instance intellectual property cases between 2021 and 2025, representing a 64.44-percent increase compared to the previous five-year period, China's top court said on Saturday. Disputes involving high-tech and cutting-edge technology sectors have continued to rise, encompassing a wide range of innovative entities such as large technology companies, small and

Adhering to the principle of equal protection for litigants at home and abroad, China is positioning itself as a preferred destination for resolving international intellectual property disputes, with more foreign entities choosing Chinese courts for such matters, officials from the country's top court said. He Zhonglin, deputy chief judge at the Supreme People's Court's Intellectual Property Court, rev

In 2025, Chinese courts handled approximately 40,000 first-instance civil and commercial cases involving foreign matters, marking a nearly 50 percent increase from the previous year, according to data released by the Supreme People's Court on Monday. "These figures reflect the courts' ongoing efforts to enhance the effectiveness of foreign-related adjudication and uphold the principle of equal protect

According to a joint decision made by the China National Intellectual Property Administration (CNIPA), the European Patent Office (EPO), the Japan Patent Office (JPO), the Ministry of Intellectual Property (MOIP) of the Republic of Korea, and the United States Patent and Trademark Office (USPTO), the IP5 Patent Prosecution Highway (PPH) pilot program will be extended for another three years, from January 6, 2026 to J